Axis Bank Limited

Transaction in Own Shares • Jan 10, 2023

National Storage Mechanism | Additional information

RNS Number : 2341M

Axis Bank Limited

10 January 2023

AXIS/CO/CS/493/2022-23

January 10, 2023

Dear Sir(s),

Sub:  Disclosure under Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015

This is with reference to our earlier letters dated April 28, 2020, July 23, 2020, August 24, 2020, October 30, 2020, February 24, 2021 and April 6, 2021, informing about the acquisition of equity shares of Max Life Insurance Company Limited ("Max Life"), a material subsidiary of Max Financial Services Limited ("Max Financial") by Axis Bank Limited ("Axis Bank") and its subsidiaries, i.e., Axis Securities Limited and Axis Capital Limited (together referred to as "Axis Entities") under definitive agreements.

Accordingly, Axis Entities had collectively acquired 12.99% of the equity share capital of Max Life. In addition, Axis Entities have a right to acquire an additional stake of upto 7.00% of the equity share capital of Max Life, in one or more tranches at a valuation as per Rule 11UA of the Income Tax Rules, 1962.

In this regard, we would like to inform you that Axis Entities have entered into revised agreements with Max Financial on January 9, 2023, agreeing that the valuation for the right to acquire the balance 7.00% equity stake of Max Life would be at Fair Market Value using Discounted Cash Flows instead of valuation as per Rule 11UA of the Income Tax Rules, 1962. This revision has been done consequent to the guidance received by Max Life from the Insurance Regulatory and Development Authority.

This is for your information and records.

Thanking you,

Yours Sincerely,

For Axis Bank Limited

Sandeep Poddar

Company Secretary

http://www.rns-pdf.londonstockexchange.com/rns/2341M_1-2023-1-10.pdf 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

MSCSFASASEDSEDF